Sanofi teams with University of Tokyo for drug discovery

By Wang Fangqing

- Last updated on GMT

Sanofi teams with University of Tokyo for drug discovery

Related tags Japan Research Innovation

Sanofi will tap Japanese academics' personalised medicine knowhow under a new collaboration with the University of Tokyo's translational research initiative (TR).

Under the agreement, Sanofi’s Japan operation in Tokyo - Sanofi K.K.- will have the access to University's research mapping system, which provides details of each TR-related research project include early and unpublished data.

The French drugmaker expects the agreement to encourage close communications between researchers in the university and the company to promote the industry-academia partnership through combining TR’s discovery of drug targets and disease mechanism with its own technologies as well as rich research resources to develop novel drugs for the global market.

The research areas that are in Sanofi’s interest include oncology, diabetes, vaccines and rare diseases​” a Sanofi K.K spokesperson told Biopharma-reporter.

She said right now there is no specific project for the collaboration and the research is not limited to biomedicine or chemical drugs. It is also not disclosed which party will fund the research if a project is selected.

In a statement, Yuji Sato, head of R&D at Sanofi K.K., said the company is actively pushing open innovation and engages itself in turning revolutionary research into effective medicines.

Apparently Sanofi is not the only one having such a strategy. Other companies in Japan working with TR for the similar purpose include Novartis, Mitsubishi Tanabe, Novo Nordisk and Takeda

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers